Novo Nordisk Pharmatech A/S — Credit Rating and Financial Key Figures
CVR number: 13246149
Københavnsvej 216, 4600 Køge
tel: 56671000
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 667.73 | 619.08 | 598.26 | 880.40 | 956.03 |
| Other operating income | 93.11 | 142.67 | 193.75 | ||
| Costs of manufacturing | - 575.97 | - 829.22 | - 938.89 | ||
| Gross profit | 145.87 | 150.86 | 22.30 | 51.18 | 17.15 |
| Costs of management | -11.37 | -15.28 | -19.69 | ||
| Costs of distribution | -23.19 | -29.28 | -46.06 | ||
| Other operating expenses | -38.98 | -58.99 | -71.67 | ||
| EBIT | 153.94 | 147.12 | 41.88 | 90.30 | 73.48 |
| Other financial income | 7.24 | 8.23 | 3.65 | ||
| Net income from associates (fin.) | 0.14 | 0.16 | 0.17 | ||
| Pre-tax profit | 114.92 | 113.75 | 49.26 | 98.69 | 77.30 |
| Income taxes | -9.95 | -21.44 | -16.68 | ||
| Net earnings | 114.92 | 113.75 | 39.31 | 77.25 | 60.62 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 174.46 | 255.60 | 287.81 | ||
| Buildings | 159.89 | 177.66 | 168.73 | ||
| Machinery and equipment | 27.68 | 34.43 | 57.22 | ||
| Advance payments and construction in progress | 99.86 | 164.45 | 505.48 | ||
| Tangible assets total | 461.90 | 632.14 | 1 019.23 | ||
| Holdings in group member companies | 1.30 | 1.50 | 1.76 | ||
| Other non-current investments | -1.50 | -1.76 | |||
| Other receivables | 745.52 | 639.92 | 1.50 | 1.76 | |
| Investments total | 745.52 | 639.92 | 1.30 | 1.50 | 1.76 |
| Long term receivables total | |||||
| Finished products/goods | 352.74 | 364.15 | 427.24 | ||
| Inventories total | 352.74 | 364.15 | 427.24 | ||
| Current trade debtors | 71.73 | 64.46 | 103.70 | ||
| Current amounts owed by group member comp. | 56.98 | 202.65 | 401.06 | ||
| Prepayments and accrued income | 0.81 | 0.98 | 7.02 | ||
| Current other receivables | 0.07 | 0.68 | 2.69 | ||
| Current deferred tax assets | 21.38 | ||||
| Short term receivables total | 150.98 | 268.77 | 514.47 | ||
| Balance sheet total (assets) | 745.52 | 639.92 | 966.91 | 1 266.56 | 1 962.70 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 606.43 | 520.25 | 10.00 | 10.00 | 10.00 |
| Other reserves | 0.13 | 0.18 | 0.27 | ||
| Retained earnings | - 114.92 | - 113.75 | 640.18 | 679.49 | 1 256.73 |
| Profit of the financial year | 114.92 | 113.75 | 39.31 | 77.25 | 60.62 |
| Shareholders equity total | 606.43 | 520.25 | 689.62 | 766.91 | 1 327.62 |
| Provisions | 43.06 | 41.20 | 41.53 | ||
| Non-current other liabilities | 41.20 | 41.53 | |||
| Non-current liabilities total | 41.20 | 41.53 | |||
| Current trade creditors | 39.14 | 48.89 | 105.68 | ||
| Current owed to group member | 160.76 | 326.61 | 387.06 | ||
| Short-term deferred tax liabilities | 5.55 | 6.99 | |||
| Other non-interest bearing current liabilities | 34.33 | 77.39 | 93.81 | ||
| Current liabilities total | 234.23 | 458.45 | 593.55 | ||
| Balance sheet total (liabilities) | 606.43 | 520.25 | 966.91 | 1 307.77 | 2 004.23 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.